arrow
Return

Redundancy in two major compound databases

delete2018-06-01
delete8
PRE
AI
D
Dimitar Yonchev
D
Dilyana Dimova
D
Dagmar Stumpfe
M
Martin Vogt
J
Jürgen Bajorath *
DOI:10.1016/j.drudis.2018.03.005delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Public repositories of compounds and activity data are of prime importance for pharmaceutical research in academic and industrial settings. Major databases have evolved over the years. Their growth is accompanied by an increasing tendency toward data sharing. This is a positive development but not without potential problems. Using ChEMBL and PubChem as examples, we show that crosstalk between databases also leads to substantial data redundancy that might not be obvious. Redundancy is an important issue because it biases data analysis and knowledge extraction and leads to inflated views of available compounds, assays and activity data. Going forward it will be important to further refine data exchange and deposition criteria and make redundancy as transparent as possible.
Keywords:
OPEN INNOVATION
CHEMBL
BINDINGDB
ZINC
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Drug Discovery Today cover
Drug Discovery Today
IF:
7.5
Papers:
6.3K
Citations:
2.3W

Organization

U
university of bonn
Scholars:
3.3W
Papers: 2.6W
Citations: 29